The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Polyoxometalates as Potential Next‐Generation Metallodrugs in the Combat Against Cancer
Open accessAbstract
Polyoxometalates (POMs) are an emerging class of inorganic metal oxides, which over the last decades demonstrated promising biological activities by the virtue of their great diversity in structures and properties. They possess high potential for the inhibition of various tumor types; however, their unspecific interactions with biomolecules and toxicity impede their clinical usage. The current focus of the field of biologically active POMs lies on organically functionalized and POM‐based nanocomposite structures as these hybrids show enhanced anticancer activity and significantly reduced toxicity towards normal cells in comparison to unmodified POMs. Although the antitumor activity of POMs is well documented, their mechanisms of action are still not well understood. In this Review, an overview is given of the cytotoxic effects of POMs with a special focus on POM‐based hybrid and nanocomposite structures. Furthermore, we aim to provide proposed mode of actions and to identify molecular targets. POMs are expected to develop into the next generation of anticancer drugs that selectively target cancer cells while sparing healthy cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Heteropoly and Isopoly Oxometalates
Pope, M. T. (1983) · Inorganic chemistry concepts · doi:10.1007/978-3-662-12004-0 · Cited by 4,749
Recent Advances in Polyoxometalate-Catalyzed Reactions
Wang, S.-S., & Yang, G.-Y. (2015) · Chemical Reviews · doi:10.1021/cr500390v · Cited by 2,160
Rhule, J. T., Hill, C. L., Judd, D. A., & Schinazi, R. F. (1998) · Chemical Reviews · doi:10.1021/cr960396q · Cited by 1,892
Biodegradation, biodistribution and toxicity of chitosan
Kean, T., & Thanou, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.004 · Cited by 1,837
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Robson, S. C., Sévigny, J., & Zimmermann, H. (2006) · Purinergic Signalling · doi:10.1007/s11302-006-9003-5 · Cited by 932
Bracci, L., Schiavoni, G., Sistigu, A., & Belardelli, F. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.67 · Cited by 928
Recent advances on polyoxometalate-based molecular and composite materials
Song, Y.-F., & Tsunashima, R. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35143a · Cited by 909
Hypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724
Cited by
Inorganic nanomaterials with rapid clearance for biomedical applications
Wang, X., Zhong, X., Li, J., Liu, Z., & Cheng, L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00461h · Cited by 509
Polyoxometalates in solution: speciation under spotlight
Gumerova, N. I., & Rompel, A. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00392a · Cited by 428
Self-citationHeterogeneous Catalysis by Polyoxometalates in Metal–Organic Frameworks
Samaniyan, M., Mirzaei, M., Khajavian, R., Eshtiagh-Hosseini, H., & Streb, C. (2019) · ACS Catalysis · doi:10.1021/acscatal.9b03439 · Cited by 389
Treviño, S., Díaz, A., Sánchez-Lara, E., Sanchez-Gaytan, B. L., Perez-Aguilar, J. M., & González-Vergara, E. (2019) · Biological Trace Element Research · doi:10.1007/s12011-018-1540-6 · Cited by 354
Cameron, J. M., Guillemot, G., Galambos, T., Amin, S. S., Hampson, E., Mall Haidaraly, K., Newton, G. N., & Izzet, G. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00832c · Cited by 260
Metadata
- Authors
- Bijelic, A., Aureliano, M., & Rompel, A.
- Venue
- Angewandte Chemie International Edition
- Publisher
- Wiley
- Published
- 2018-10-12
- Volume
- 58
- Issue
- 10
- Pages
- 2980-2999
- ISSN
- 1433-7851 (ISSN-L)
- 1521-3773
- OpenAlex
- W2808519915
- Cited by
- 611
- References
- 69
- FWCI
- 19.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.